The HEADWIND Study - Part 4

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 13, 2022

Primary Completion Date

June 23, 2022

Study Completion Date

June 23, 2022

Conditions
DiabetesDiabetes Mellitus, Type 1
Interventions
OTHER

Controlled hypoglycaemic state while driving

Participants will drive on a designated circuit with a real car on a test track accompanied by a driving instructor. Initially, a euglycaemic state (5.0 - 8.0 mmol/L) is established and blood glucose is then declined to hypoglycaemia (3.0 - 3.5 mmol/L) by administering insulin. Thereafter, blood glucose is raised again to euglycaemia (5.0 - 8.0mmol/L). During the procedure, driving data is recorded. Additionally, eye movement, head pose, facial expression, heart rate, skin conductance, and CGM values are recorded throughout the glycemic trajectory. Participants are blinded to the blood glucose values during the procedure.

Trial Locations (1)

Unknown

University Department of Endocrinology, Diabetology, Clinical Nutrition and Metabolism, Bern

All Listed Sponsors
collaborator

Swiss Federal Institute of Technology

OTHER

collaborator

University of St.Gallen

OTHER

lead

Insel Gruppe AG, University Hospital Bern

OTHER